Clinical Trial Update: Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

View source ↗

Summary

Expanded-access intermediate-size treatment protocol for pritelivir to treat immunocompromised patients with treatment-resistant herpes simplex virus infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection

Drugs mentioned

• Pritelivir (pritelivir)

Snippet

Sponsor: AiCuris Anti-infective Cures AG | Conditions: HSV | Status: AVAILABLE